Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies. [PDF]
Zhang M +9 more
europepmc +1 more source
The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. [PDF]
Bilgetekin I +5 more
europepmc +1 more source
A patient-derived ccRCC model that retains native stromal features to assess fibrosis-driven personalized therapeutic response. [PDF]
Perreault A +8 more
europepmc +1 more source
Late-Onset Normotensive Thrombotic Microangiopathy and Pyoderma Gangrenosum Following Nine Years of Sunitinib Therapy: A Case Report. [PDF]
Saiki R +6 more
europepmc +1 more source
Tyrosine Kinase Receptors, Inhibition, and Potential Role in the Pharmacotherapy of Retinal Disorders. [PDF]
Venkatesh P.
europepmc +1 more source
GFPT2 drives sunitinib resistance of renal cell carcinoma via enzyme-dependent and -independent manners. [PDF]
Wang S +5 more
europepmc +1 more source
PDZK1-ULK1 Axis Triggers Lipophagy to Inhibit Tumor Progression and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. [PDF]
Qi X +11 more
europepmc +1 more source
Emerging mechanisms of kinase inhibitor escape and clinical implications of ponatinib in advanced gastrointestinal stromal tumor. [PDF]
Shenoy S.
europepmc +1 more source
Numb-Associated Kinases-Mediated AP2M1 Activation Facilitates Porcine Reproductive and Respiratory Syndrome Virus Entry. [PDF]
Zhang L +7 more
europepmc +1 more source
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0. [PDF]
McKay RR +18 more
europepmc +1 more source

